Fyn Phosphorylates Transglutaminase 2 (Tgm2) and Modulates Autophagy and p53 Expression in the Development of Diabetic Kidney Disease

Autophagy is involved in the development of diabetic kidney disease (DKD), the leading cause of end-stage renal disease. The Fyn tyrosine kinase (Fyn) suppresses autophagy in the muscle. However, its role in kidney autophagic processes is unclear. Here, we examined the role of Fyn kinase in autophagy in proximal renal tubules both in vivo and in vitro. Phospho-proteomic analysis revealed that transglutaminase 2 (Tgm2), a protein involved in the degradation of p53 in the autophagosome, is phosphorylated on tyrosine 369 (Y369) by Fyn. Interestingly, we found that Fyn-dependent phosphorylation of Tgm2 regulates autophagy in proximal renal tubules in vitro, and that p53 expression is decreased upon autophagy in Tgm2-knockdown proximal renal tubule cell models. Using streptozocin (STZ)-induced hyperglycemic mice, we confirmed that Fyn regulated autophagy and mediated p53 expression via Tgm2. Taken together, these data provide a molecular basis for the role of the Fyn–Tgm2–p53 axis in the development of DKD.

[1]  H. Tatsukawa,et al.  Role of Transglutaminase 2 in Cell Death, Survival, and Fibrosis , 2021, Cells.

[2]  H. Ding,et al.  p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease. , 2020, The Journal of clinical investigation.

[3]  Z. Dong,et al.  Autophagy in kidney homeostasis and disease , 2020, Nature Reviews Nephrology.

[4]  S. Oh,et al.  Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma , 2020, Cells.

[5]  Md Jamal Uddin,et al.  Fyn Kinase: A Potential Therapeutic Target in Acute Kidney Injury , 2020, Biomolecules & therapeutics.

[6]  Linghong Huang,et al.  Insights on the heparan sulphate-dependent externalisation of transglutaminase-2 (TG2) in glucose-stimulated proximal-like tubular epithelial cells. , 2020, Analytical biochemistry.

[7]  K. Gomes,et al.  Anti-inflammatory effects of C-peptide on kidney of type 1 diabetes mellitus animal model , 2019, Molecular Biology Reports.

[8]  Anna E Argento,et al.  FYN tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates anti-glioma immune responses , 2019, bioRxiv.

[9]  Chao-Yung Wang,et al.  Autophagy in Chronic Kidney Diseases , 2019, Cells.

[10]  Kyung Lee,et al.  Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury. , 2018, Kidney international.

[11]  Yue Wang,et al.  Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease , 2018, Journal of Translational Medicine.

[12]  Y. Isaka,et al.  High-Fat Diet-Induced Lysosomal Dysfunction and Impaired Autophagic Flux Contribute to Lipotoxicity in the Kidney. , 2017, Journal of the American Society of Nephrology : JASN.

[13]  J. Hughes,et al.  Renal Aging: Causes and Consequences. , 2017, Journal of the American Society of Nephrology : JASN.

[14]  Yu Zhang,et al.  Beclin-1- mediated autophagy may be involved in the elderly cognitive and affective disorders in streptozotocin-induced diabetic mice , 2016, Translational Neurodegeneration.

[15]  E. Tremoli,et al.  Inhibition of transglutaminase 2 reduces efferocytosis in human macrophages: Role of CD14 and SR-AI receptors. , 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[16]  K. Utsunomiya,et al.  Signaling pathways in diabetic nephropathy. , 2016, Histology and histopathology.

[17]  S. Zhuang,et al.  Autophagy in Chronic Kidney Diseases , 2016, Kidney Diseases.

[18]  B. Bay,et al.  Transglutaminase 2 contributes to a TP53-induced autophagy program to prevent oncogenic transformation , 2016, eLife.

[19]  D. Hong,et al.  Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy , 2016, Cell Death and Disease.

[20]  B. Furman,et al.  Streptozotocin‐Induced Diabetic Models in Mice and Rats , 2015, Current protocols in pharmacology.

[21]  Z. Dong,et al.  Tubular p53 regulates multiple genes to mediate AKI. , 2014, Journal of the American Society of Nephrology : JASN.

[22]  Myung-Shik Lee,et al.  Autophagy—a key player in cellular and body metabolism , 2014, Nature Reviews Endocrinology.

[23]  H. Kwon,et al.  Fyn Deficiency Promotes a Preferential Increase in Subcutaneous Adipose Tissue Mass and Decreased Visceral Adipose Tissue Inflammation , 2013, Diabetes.

[24]  A. Cuervo,et al.  Mouse skeletal muscle fiber-type-specific macroautophagy and muscle wasting are regulated by a Fyn/STAT3/Vps34 signaling pathway. , 2012, Cell reports.

[25]  Sangeeta Khare,et al.  Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition) , 2016 .

[26]  G. Johnson,et al.  Transglutaminase 2 and its role in pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.

[27]  Y. Isaka,et al.  The protective role of autophagy against aging and acute ischemic injury in kidney proximal tubular cells , 2011, Autophagy.

[28]  M. Komatsu,et al.  Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder—murine Pompe disease , 2010, Autophagy.

[29]  A. Ballabio,et al.  Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition , 2010, Nature Cell Biology.

[30]  J. Pessin,et al.  Fyn-dependent regulation of energy expenditure and body weight is mediated by tyrosine phosphorylation of LKB1. , 2010, Cell metabolism.

[31]  C. Alpers,et al.  Mouse models of diabetic nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.

[32]  G. Melino,et al.  Transglutaminase 2 is involved in autophagosome maturation , 2009, Autophagy.

[33]  M. Czaja,et al.  Autophagy regulates adipose mass and differentiation in mice. , 2009, The Journal of clinical investigation.

[34]  M. Czaja,et al.  Autophagy regulates lipid metabolism , 2009, Nature.

[35]  Kun Wook Chung,et al.  Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia. , 2008, Cell metabolism.

[36]  Masaaki Komatsu,et al.  Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. , 2008, Cell metabolism.

[37]  J. Pessin,et al.  Integrative metabolic regulation of peripheral tissue fatty acid oxidation by the SRC kinase family member Fyn. , 2007, Cell metabolism.

[38]  M. Rossmeisl,et al.  Variation in type 2 diabetes--related traits in mouse strains susceptible to diet-induced obesity. , 2003, Diabetes.

[39]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[40]  S. Scherer,et al.  X‐linked vacuolar myopathies: Two separate loci and refined genetic mapping , 2000, Annals of neurology.

[41]  Ronit Vogt Sionov,et al.  The cellular response to p53: the decision between life and death , 1999, Oncogene.

[42]  A. Engin What Is Lipotoxicity? , 2017, Advances in experimental medicine and biology.

[43]  Yunchao Su,et al.  Induction of microRNA-17-5p by p53 protects against renal ischemia-reperfusion injury by targeting death receptor 6. , 2017, Kidney international.

[44]  C. Greenberg,et al.  TGM2 and implications for human disease: role of alternative splicing. , 2013, Frontiers in bioscience.

[45]  R. Zager,et al.  HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. , 1994, Kidney international.